TP53 and cancer: While as expected tumors were observed in Rnf8−/− and p53−/− mice, double mutants displayed higher cancer risk compared to single mutant littermates (Log-rank test, P<0.0001 compared to Rnf8−/− mice and P = 0.0004 compared to p53−/− mice; Figure 10A).